Health Canada Approves Updates To Mifegymiso Prescribing Information: Ultrasound No Longer Mandatory
Recall Summary Health Canada has updated the prescribing information for Mifegymiso (a medication used to end early pregnancy) to remove the requirement for an ultrasound before use. The change applies to all Canadian patients and healthcare providers who prescribe or use this medication. This is an informational update to how the drug can be used, not a safety recall of the product itself.
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2019-04-16
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/059901ed-4349-4f8c-ba6b-bd4524887359